Along the same lines, Qin et al. (2024) reported that postbiotics derived from SbS significantly attenuated intestinal inflammation in DSS-induced colitis models, primarily through the activation of the epidermal growth factor receptor (EGFR) [22]. This evidence concerns the gene EGFR and colitis.